Grayson Wilkes Armstrong, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Eye Injuries, Penetrating | 10 | 2024 | 115 | 5.890 |
Why?
|
Eye Injuries | 9 | 2023 | 245 | 3.630 |
Why?
|
Ophthalmology | 7 | 2022 | 508 | 1.590 |
Why?
|
Telemedicine | 8 | 2023 | 2872 | 1.220 |
Why?
|
Cataract | 2 | 2023 | 834 | 1.100 |
Why?
|
Eye Foreign Bodies | 2 | 2024 | 55 | 0.970 |
Why?
|
Eye Diseases | 4 | 2021 | 669 | 0.890 |
Why?
|
Lacerations | 1 | 2023 | 144 | 0.830 |
Why?
|
Vitreoretinopathy, Proliferative | 1 | 2022 | 68 | 0.830 |
Why?
|
Tomography, Optical Coherence | 8 | 2021 | 2657 | 0.820 |
Why?
|
Lenses, Intraocular | 1 | 2023 | 140 | 0.820 |
Why?
|
Lens, Crystalline | 1 | 2023 | 388 | 0.800 |
Why?
|
Retinal Vein | 1 | 2021 | 47 | 0.770 |
Why?
|
Retinal Detachment | 2 | 2022 | 411 | 0.750 |
Why?
|
Retinal Artery | 1 | 2021 | 111 | 0.720 |
Why?
|
Oculomotor Muscles | 1 | 2023 | 371 | 0.690 |
Why?
|
Cataract Extraction | 1 | 2023 | 481 | 0.680 |
Why?
|
Eye Infections, Bacterial | 1 | 2022 | 235 | 0.670 |
Why?
|
Posterior Eye Segment | 1 | 2018 | 14 | 0.670 |
Why?
|
Keratitis | 1 | 2022 | 268 | 0.660 |
Why?
|
Corneal Diseases | 2 | 2022 | 636 | 0.660 |
Why?
|
Cavernous Sinus | 1 | 2019 | 125 | 0.640 |
Why?
|
Blepharoptosis | 1 | 2019 | 143 | 0.630 |
Why?
|
Ophthalmoplegia | 1 | 2019 | 166 | 0.630 |
Why?
|
Ophthalmologic Surgical Procedures | 1 | 2021 | 349 | 0.610 |
Why?
|
Presenilin-1 | 1 | 2021 | 635 | 0.590 |
Why?
|
Emergencies | 1 | 2023 | 1170 | 0.580 |
Why?
|
Carotid Artery, Internal | 1 | 2019 | 445 | 0.570 |
Why?
|
Aneurysm | 1 | 2019 | 339 | 0.550 |
Why?
|
Device Removal | 1 | 2021 | 656 | 0.530 |
Why?
|
Curriculum | 5 | 2022 | 3605 | 0.520 |
Why?
|
Blindness | 1 | 2019 | 617 | 0.510 |
Why?
|
Visual Acuity | 9 | 2024 | 2530 | 0.480 |
Why?
|
Communicable Diseases | 1 | 2022 | 880 | 0.450 |
Why?
|
Carotid Artery Diseases | 1 | 2019 | 882 | 0.440 |
Why?
|
Artificial Intelligence | 3 | 2022 | 2214 | 0.440 |
Why?
|
Retinal Drusen | 3 | 2017 | 66 | 0.430 |
Why?
|
Diabetic Retinopathy | 3 | 2019 | 1210 | 0.430 |
Why?
|
Wounds, Nonpenetrating | 1 | 2018 | 794 | 0.410 |
Why?
|
Choroid | 3 | 2019 | 322 | 0.410 |
Why?
|
Retrospective Studies | 22 | 2024 | 77449 | 0.390 |
Why?
|
Policy Making | 1 | 2015 | 554 | 0.390 |
Why?
|
Fractures, Bone | 1 | 2023 | 1947 | 0.390 |
Why?
|
Health Knowledge, Attitudes, Practice | 2 | 2017 | 3923 | 0.380 |
Why?
|
Writing | 1 | 2013 | 206 | 0.380 |
Why?
|
Macular Edema | 1 | 2014 | 359 | 0.370 |
Why?
|
Lens Implantation, Intraocular | 2 | 2023 | 192 | 0.360 |
Why?
|
Emergency Service, Hospital | 5 | 2023 | 7659 | 0.350 |
Why?
|
Inpatients | 1 | 2021 | 2518 | 0.340 |
Why?
|
Health Services | 1 | 2014 | 758 | 0.330 |
Why?
|
Eye | 3 | 2023 | 729 | 0.330 |
Why?
|
Accidents, Traffic | 1 | 2014 | 819 | 0.330 |
Why?
|
Fluorescein Angiography | 6 | 2019 | 940 | 0.310 |
Why?
|
Education, Medical, Undergraduate | 1 | 2015 | 1008 | 0.280 |
Why?
|
Humans | 49 | 2024 | 744343 | 0.270 |
Why?
|
Cross-Sectional Studies | 9 | 2023 | 25043 | 0.250 |
Why?
|
Cornea | 2 | 2022 | 1524 | 0.240 |
Why?
|
Students, Medical | 1 | 2017 | 1862 | 0.230 |
Why?
|
Retinal Pigment Epithelium | 2 | 2017 | 302 | 0.230 |
Why?
|
Health Policy | 1 | 2015 | 2661 | 0.220 |
Why?
|
Mucopolysaccharidoses | 1 | 2022 | 27 | 0.210 |
Why?
|
Mucopolysaccharidosis I | 1 | 2022 | 50 | 0.200 |
Why?
|
Diplopia | 1 | 2023 | 200 | 0.200 |
Why?
|
Endophthalmitis | 1 | 2024 | 262 | 0.190 |
Why?
|
Education, Medical | 1 | 2013 | 1721 | 0.190 |
Why?
|
Keratoconus | 1 | 2022 | 121 | 0.180 |
Why?
|
Anterior Chamber | 1 | 2021 | 197 | 0.180 |
Why?
|
Colombia | 1 | 2021 | 258 | 0.180 |
Why?
|
Optometry | 1 | 2020 | 30 | 0.180 |
Why?
|
Anterior Eye Segment | 1 | 2021 | 152 | 0.180 |
Why?
|
Smoking | 1 | 2017 | 8987 | 0.180 |
Why?
|
Alzheimer Disease | 1 | 2021 | 8037 | 0.180 |
Why?
|
School Admission Criteria | 1 | 2020 | 105 | 0.180 |
Why?
|
Ophthalmoscopy | 1 | 2019 | 176 | 0.170 |
Why?
|
Personnel Selection | 1 | 2020 | 189 | 0.160 |
Why?
|
Vision, Low | 1 | 2021 | 168 | 0.160 |
Why?
|
Sclera | 1 | 2020 | 200 | 0.160 |
Why?
|
Financial Management | 1 | 2020 | 160 | 0.160 |
Why?
|
Female | 25 | 2023 | 380194 | 0.160 |
Why?
|
Phacoemulsification | 1 | 2020 | 149 | 0.160 |
Why?
|
Choroiditis | 1 | 2017 | 12 | 0.150 |
Why?
|
Bruch Membrane | 1 | 2017 | 64 | 0.150 |
Why?
|
Corneal Transplantation | 1 | 2022 | 386 | 0.150 |
Why?
|
Varicose Veins | 1 | 2019 | 154 | 0.150 |
Why?
|
Photography | 1 | 2021 | 520 | 0.150 |
Why?
|
Professional Practice | 1 | 2020 | 326 | 0.150 |
Why?
|
Rupture | 1 | 2018 | 433 | 0.150 |
Why?
|
Age of Onset | 2 | 2021 | 3271 | 0.150 |
Why?
|
Male | 20 | 2023 | 350118 | 0.150 |
Why?
|
Face | 1 | 2023 | 994 | 0.150 |
Why?
|
Fovea Centralis | 1 | 2017 | 119 | 0.140 |
Why?
|
Private Sector | 1 | 2020 | 392 | 0.140 |
Why?
|
Trauma Severity Indices | 1 | 2018 | 481 | 0.140 |
Why?
|
Pandemics | 3 | 2021 | 8388 | 0.140 |
Why?
|
Otolaryngology | 1 | 2023 | 645 | 0.140 |
Why?
|
Mutation | 1 | 2021 | 29786 | 0.140 |
Why?
|
Prognosis | 4 | 2024 | 29063 | 0.130 |
Why?
|
Early Diagnosis | 1 | 2021 | 1184 | 0.130 |
Why?
|
Aged | 13 | 2023 | 163280 | 0.130 |
Why?
|
Wet Macular Degeneration | 1 | 2017 | 145 | 0.130 |
Why?
|
Prostheses and Implants | 1 | 2022 | 1387 | 0.130 |
Why?
|
Steroids | 1 | 2020 | 930 | 0.130 |
Why?
|
Retinal Vessels | 2 | 2017 | 772 | 0.130 |
Why?
|
Italy | 1 | 2017 | 832 | 0.120 |
Why?
|
Choroidal Neovascularization | 1 | 2017 | 343 | 0.120 |
Why?
|
Fundus Oculi | 3 | 2022 | 473 | 0.120 |
Why?
|
Educational Measurement | 1 | 2020 | 1210 | 0.120 |
Why?
|
Young Adult | 8 | 2022 | 56430 | 0.110 |
Why?
|
Retinal Neovascularization | 1 | 2016 | 244 | 0.110 |
Why?
|
United States | 9 | 2023 | 69872 | 0.110 |
Why?
|
Magnetic Resonance Angiography | 1 | 2019 | 1442 | 0.110 |
Why?
|
Middle Aged | 12 | 2023 | 213383 | 0.100 |
Why?
|
Sex Factors | 2 | 2017 | 10397 | 0.100 |
Why?
|
Child, Preschool | 4 | 2021 | 41006 | 0.100 |
Why?
|
Amyloid Neuropathies, Familial | 1 | 2013 | 138 | 0.090 |
Why?
|
Eye Pain | 2 | 2022 | 47 | 0.090 |
Why?
|
Infant | 3 | 2021 | 35136 | 0.090 |
Why?
|
Angiography | 1 | 2016 | 1639 | 0.090 |
Why?
|
Internship and Residency | 2 | 2020 | 5788 | 0.090 |
Why?
|
Venous Thrombosis | 1 | 2019 | 1239 | 0.090 |
Why?
|
Patient Protection and Affordable Care Act | 1 | 2019 | 1209 | 0.090 |
Why?
|
Age Factors | 2 | 2017 | 18370 | 0.080 |
Why?
|
Insurance Coverage | 1 | 2019 | 1901 | 0.080 |
Why?
|
Boston | 1 | 2021 | 9313 | 0.080 |
Why?
|
Tomography, X-Ray Computed | 2 | 2021 | 20129 | 0.070 |
Why?
|
Follow-Up Studies | 3 | 2023 | 39050 | 0.070 |
Why?
|
Child | 5 | 2021 | 77709 | 0.070 |
Why?
|
Adolescent | 5 | 2021 | 85781 | 0.070 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2019 | 2104 | 0.070 |
Why?
|
Medicare | 2 | 2023 | 6566 | 0.070 |
Why?
|
Sex Distribution | 1 | 2012 | 2297 | 0.070 |
Why?
|
Medicaid | 1 | 2019 | 2736 | 0.070 |
Why?
|
Age Distribution | 1 | 2012 | 2902 | 0.070 |
Why?
|
Adult | 9 | 2022 | 214055 | 0.070 |
Why?
|
Clinical Competence | 1 | 2020 | 4687 | 0.060 |
Why?
|
Predictive Value of Tests | 1 | 2021 | 15076 | 0.060 |
Why?
|
Smoking Cessation | 1 | 2017 | 2071 | 0.060 |
Why?
|
Immunotherapy | 1 | 2020 | 4445 | 0.060 |
Why?
|
Diagnosis, Differential | 1 | 2019 | 12959 | 0.060 |
Why?
|
Prospective Studies | 4 | 2022 | 53288 | 0.060 |
Why?
|
Random Amplified Polymorphic DNA Technique | 1 | 2022 | 19 | 0.060 |
Why?
|
Cognition | 1 | 2021 | 6770 | 0.060 |
Why?
|
Phenotype | 1 | 2021 | 16365 | 0.060 |
Why?
|
Infant, Newborn | 2 | 2014 | 25625 | 0.060 |
Why?
|
Case-Control Studies | 1 | 2021 | 21746 | 0.050 |
Why?
|
Attitude of Health Personnel | 1 | 2017 | 3843 | 0.050 |
Why?
|
Disease Progression | 1 | 2019 | 13284 | 0.050 |
Why?
|
Health Services Accessibility | 1 | 2019 | 5137 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3133 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3240 | 0.050 |
Why?
|
Databases, Factual | 2 | 2020 | 7729 | 0.050 |
Why?
|
Keratoplasty, Penetrating | 1 | 2022 | 155 | 0.050 |
Why?
|
Emergency Medical Services | 1 | 2012 | 1917 | 0.040 |
Why?
|
Pseudophakia | 1 | 2020 | 62 | 0.040 |
Why?
|
Prevalence | 1 | 2017 | 15226 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 1 | 2021 | 17446 | 0.040 |
Why?
|
Specialty Boards | 1 | 2020 | 227 | 0.040 |
Why?
|
Immunization, Passive | 1 | 2020 | 623 | 0.040 |
Why?
|
Colloids | 1 | 2017 | 136 | 0.040 |
Why?
|
Demyelinating Diseases | 1 | 2020 | 354 | 0.040 |
Why?
|
Geography | 1 | 2020 | 669 | 0.040 |
Why?
|
Mycophenolic Acid | 1 | 2019 | 343 | 0.040 |
Why?
|
Pediatrics | 1 | 2012 | 3475 | 0.040 |
Why?
|
Indocyanine Green | 1 | 2017 | 239 | 0.030 |
Why?
|
Coloring Agents | 1 | 2017 | 566 | 0.030 |
Why?
|
Triage | 1 | 2022 | 976 | 0.030 |
Why?
|
Vision Disorders | 1 | 2022 | 1058 | 0.030 |
Why?
|
Disease Transmission, Infectious | 1 | 2020 | 547 | 0.030 |
Why?
|
Intraocular Pressure | 1 | 2020 | 1270 | 0.030 |
Why?
|
Hormone Replacement Therapy | 1 | 2019 | 745 | 0.030 |
Why?
|
Aged, 80 and over | 4 | 2022 | 57776 | 0.030 |
Why?
|
Accidents, Home | 1 | 2013 | 75 | 0.030 |
Why?
|
Regional Blood Flow | 1 | 2016 | 1525 | 0.030 |
Why?
|
Syndrome | 1 | 2017 | 3251 | 0.020 |
Why?
|
Antirheumatic Agents | 1 | 2020 | 1339 | 0.020 |
Why?
|
Testosterone | 1 | 2019 | 2420 | 0.020 |
Why?
|
Recurrence | 1 | 2020 | 8340 | 0.020 |
Why?
|
Incidence | 2 | 2019 | 20947 | 0.020 |
Why?
|
Education, Medical, Graduate | 1 | 2020 | 2291 | 0.020 |
Why?
|
Immunosuppressive Agents | 1 | 2020 | 4149 | 0.020 |
Why?
|
Multiple Sclerosis | 1 | 2020 | 3079 | 0.020 |
Why?
|
Mass Screening | 1 | 2020 | 5255 | 0.020 |
Why?
|
Imaging, Three-Dimensional | 1 | 2017 | 4042 | 0.010 |
Why?
|
Diabetes Mellitus | 1 | 2019 | 5751 | 0.010 |
Why?
|
Algorithms | 1 | 2020 | 13881 | 0.010 |
Why?
|
Risk Factors | 1 | 2024 | 72290 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2022 | 63114 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2019 | 35421 | 0.010 |
Why?
|